Saunderson P - Search Results

1

Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy.

Bochud PY, Hawn TR, Siddiqui MR, Saunderson P, Britton S, Abraham I, Argaw AT, Janer M, Zhao LP, Kaplan G, Aderem A. Bochud PY, et al. Among authors: saunderson p. J Infect Dis. 2008 Jan 15;197(2):253-61. doi: 10.1086/524688. J Infect Dis. 2008. PMID: 18177245 Free PMC article.

2

Polymorphisms in Toll-like receptor 4 (TLR4) are associated with protection against leprosy.

Bochud PY, Sinsimer D, Aderem A, Siddiqui MR, Saunderson P, Britton S, Abraham I, Tadesse Argaw A, Janer M, Hawn TR, Kaplan G. Bochud PY, et al. Among authors: saunderson p. Eur J Clin Microbiol Infect Dis. 2009 Sep;28(9):1055-65. doi: 10.1007/s10096-009-0746-0. Epub 2009 May 9. Eur J Clin Microbiol Infect Dis. 2009. PMID: 19430824 Free PMC article.

3

The potential for vaccination in leprosy elimination: new tools for targeted interventions.

Duthie MS, Saunderson P, Reed SG. Duthie MS, et al. Among authors: saunderson p. Mem Inst Oswaldo Cruz. 2012 Dec;107 Suppl 1:190-6. doi: 10.1590/s0074-02762012000900027. Mem Inst Oswaldo Cruz. 2012. PMID: 23283471 Free article.

4

An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP+.

Mieras LF, Taal AT, van Brakel WH, Cambau E, Saunderson PR, Smith WCS, Prakoeswa CRS, Astari L, Scollard DM, do Nascimento DC, Grosset J, Kar HK, Izumi S, Gillini L, Virmond MCL, Sturkenboom MGG. Mieras LF, et al. BMC Infect Dis. 2018 Oct 5;18(1):506. doi: 10.1186/s12879-018-3402-4. BMC Infect Dis. 2018. PMID: 30290790 Free PMC article.

5

Leprosy elimination: not as straightforward as it seemed.

Saunderson PR. Saunderson PR. Public Health Rep. 2008 Mar-Apr;123(2):213-6. doi: 10.1177/003335490812300214. Public Health Rep. 2008. PMID: 18457074 Free PMC article. No abstract available.

6

Reversal reactions in the skin lesions of AMFES patients: incidence and risk factors.

Saunderson P, Gebre S, Byass P. Saunderson P, et al. Lepr Rev. 2000 Sep;71(3):309-17. doi: 10.5935/0305-7518.20000034. Lepr Rev. 2000. PMID: 11105489

7

Neuropathic pain in people treated for multibacillary leprosy more than ten years previously.

Saunderson P, Bizuneh E, Leekassa R. Saunderson P, et al. Lepr Rev. 2008 Sep;79(3):270-6. Lepr Rev. 2008. PMID: 19009976

8

Factors associated with impairments in new leprosy patients: the AMFES cohort.

Meima A, Saunderson PR, Gebre S, Desta K, van Oortmarssen GJ, Habbema JD. Meima A, et al. Among authors: saunderson pr. Lepr Rev. 1999 Jun;70(2):189-203. doi: 10.5935/0305-7518.19990022. Lepr Rev. 1999. PMID: 10464437

9

Rational design and evaluation of a multiepitope chimeric fusion protein with the potential for leprosy diagnosis.

Duthie MS, Hay MN, Morales CZ, Carter L, Mohamath R, Ito L, Oyafuso LK, Manini MI, Balagon MV, Tan EV, Saunderson PR, Reed SG, Carter D. Duthie MS, et al. Among authors: saunderson pr. Clin Vaccine Immunol. 2010 Feb;17(2):298-303. doi: 10.1128/CVI.00400-09. Epub 2009 Dec 16. Clin Vaccine Immunol. 2010. PMID: 20016045 Free PMC article.

10

ENL reactions in the multibacillary cases of the AMFES cohort in central Ethiopia: incidence and risk factors.

Saunderson P, Gebre S, Byass P. Saunderson P, et al. Lepr Rev. 2000 Sep;71(3):318-24. doi: 10.5935/0305-7518.20000035. Lepr Rev. 2000. PMID: 11105490

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters